Trial Profile
Intensive Exenatide Therapy in Hyperglycemic Patients Admitted to the Coronary Intensive Care Unit
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2014
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Hyperglycaemia
- Focus Therapeutic Use
- 22 Aug 2012 New trial record